Knowstox

Fundamentals snapshot

The Pennant Group, Inc.

PNTG · NMS · Healthcare · Medical Care Facilities

Current price

$41.66

52-week range

$22.25 - $43.41

Market cap

$1.46B

One-glance verdict

Overvalued

$11.61 our estimate vs market $41.66

Wall Street consensus: $46.83 (303.6% higher than our fair-value estimate)

Balance sheet

Stretched

7.62x Adequate

Net debt $480.28M. Interest coverage shows how many times profit covers the interest bill.

What this company does

The Pennant Group, Inc.

The Pennant Group offers healthcare services like home health and senior living in the US, with most of its money coming from providing care to patients in their homes or in senior living facilities. This matters because it shows how the company makes money by helping people who need ongoing medical and personal support.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $6.79M FY2024 Q4 $17.25M FY2025 Q1 $-23.19M FY2025 Q2 $31.58M FY2025 Q3 $10.47M FY2025 Q4 $17.40M FY2026 Q1 $-8.68M FY2026 Q2 $15.49M
Revenue $297.98M
Net income $9.08M
Diluted EPS 0.25
Operating cash flow $21.83M
Free cash flow $15.49M
Revenue $285.36M
Net income $8.52M
Diluted EPS 0.24
Operating cash flow $-3.40M
Free cash flow $-8.68M
Revenue $289.32M
Net income $8.64M
Diluted EPS 0.25
Operating cash flow $20.96M
Free cash flow $17.40M
Revenue $229.04M
Net income $6.08M
Diluted EPS 0.17
Operating cash flow $13.92M
Free cash flow $10.47M
Revenue $219.50M
Net income $7.08M
Diluted EPS 0.20
Operating cash flow $34.64M
Free cash flow $31.58M
Revenue $209.84M
Net income $7.78M
Diluted EPS 0.22
Operating cash flow $-21.23M
Free cash flow $-23.19M
Revenue $188.89M
Net income $5.76M
Diluted EPS 0.16
Operating cash flow $20.57M
Free cash flow $17.25M
Revenue $180.69M
Net income $6.21M
Diluted EPS 0.20
Operating cash flow $7.69M
Free cash flow $6.79M

Is it cheap or expensive?

Fair value $11.61 vs current price $41.66

Wall Street consensus is the average analyst price target: $46.83 (303.6% higher than our fair-value estimate).

Our most-likely fair value is $11.61 a share — about 72.1% below today's price of $41.66, so the stock currently looks expensive (overvalued).

overvalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 10.0% · Discount 9.3% · Terminal 3.0%

$11.61

Bear

Growth 5.0% · Discount 9.3% · Terminal 3.0%

$5.40

Bull

Growth 18.0% · Discount 9.3% · Terminal 3.0%

$25.55

Is it drowning in debt?

Stretched

Net debt $480.3M. Interest coverage 7.6x.

Net debt $480.28M
Interest coverage 7.62x

The Pennant Group, Inc.'s profit covers its interest bill about 7.6 times over. which is stronger than most peers shown here and 2 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.

Stretched
Worse cushion Baseline Better cushion
PNTG BASELINE The Pennant Group, Inc.

Total debt $495.55M Interest coverage 7.62x This is the baseline the peer rows are being compared against.

Total debt $86.95M Interest coverage 1.36x -82% vs PNTG Carries about 5.6x less debt cushion than PNTG.

Total debt $108.82M Interest coverage 10.18x +34% vs PNTG Carries about 1.3x more debt cushion than PNTG.

Total debt $1.57B Interest coverage -0.35x -100% vs PNTG This peer has almost no interest-payment cushion compared with PNTG.

Total debt $5.49B Interest coverage 0.36x -95% vs PNTG Carries about 21.0x less debt cushion than PNTG.

What you should know

The case for and against PNTG

3 Rewards 2 Risks

Rewards

  • Revenue grew 16.3% last year.
  • Returns 10.4% on equity, ahead of 83% of its peers.
  • Free cash flow was positive in 7/10 years.

Risks

  • Net debt grew 34.4% over 3 years.
  • Stock trades 19.7% above its 5-year average P/E.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
45.78x
Forward P/E
26.25x
P/B
4.07x
P/S
1.32x
EV/EBITDA
26.56x
PEG ratio
2.05x

Profitability

How much profit each dollar creates

Gross margin
19.6%
Operating margin
6.2%
Net margin
2.9%
ROE
10.4%
ROA
4.5%

Health

Liquidity and balance-sheet strength

Debt / equity
1.23x
Current ratio
1.21x
Quick ratio
0.97x
Total debt
$495.55M
Total cash
$15.27M

Growth

How the business has been compounding

Revenue TTM
$1.10B
Revenue 5Y CAGR
21.2%
EPS TTM
0.91
EPS 5Y CAGR
56.3%

Cash flow

How much cash the business throws off

Operating CF TTM
$53.30M
Free CF TTM
$36.26M
FCF margin
3.3%

Dividend

Shareholder payout

Yield
0.0%
Payout ratio
0.0%
Last ex-div date
—